Self-hypnosis Training for Chronic Pain Management
ConditionHypnosis, Chronic Pain Management
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCiusss de L'Est de l'Île de Montréal
About this trial
Title: Self-hypnosis training in chronic pain management: A pilot study Our primary objective concerns the effect of hypnosis intervention on change in 24h pain between T0 (pre-intervention) and T4 (3-month follow-up). The secondary objectives concern the effects of the intervention on (i) change in 24h pain between T0 and T5 (6-month follow-up), (ii) changes from T0 in measures of the functional impact of pain, (iii) changes from T0 in anxiety-depression scores and (iv) changes from T0 in quality of life.
The study design is a Randomized efficacy pilot study. The study focuses on patients practicing self-hypnosis within HMR groups. The study population is pain clinic patients. The sample size is 60 pain clinic patients. Study duration: February 2024 - December 2024. Center responsible for the study: Centre de Recherche de l'Hôpital Maisonneuve-Rosemont (CR-HMR) - CEMTL, Montreal, Quebec, Canada.
Adverse events: none expected.
Eligibility criteria
Qualifiers
Inclusion criteria were to have participated in the past year in the self-hypnosis training program and to agree to take part in these research interviews.
be 18 years of age or older;
have received one of the above diagnoses, confirmed by medical record review or physician confirmation;
report pain that has been present for at least 3 months;
Disqualifiers
have deafness and/or severe cognitive impairment that may impair communication;
have current or recent psychiatric instability (e.g., active suicidal ideation, active delusional or psychotic thoughts) that could interfere with participation, as assessed by a clinical psychologist.
Trial design
Treatments tested in this trial
- Self-hypnosis
- Psycho-education and cognitive Bahavioral therapy (CBT)
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov